Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)

BACKGROUND: Metastatic colorectal cancer (mCRC) with wild type expression of RAS and RAF genes can be treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, such as cetuximab, in combination with chemotherapy. Skin toxicity represents the most serious and frequent side effe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Oncol
Hlavní autoři: De Luca, Rossella, Lo Coco, Gianluca, Addeo, Raffaele, Fattoruso, Silvia Ileana Sara, Auriemma, Annunziata, Paci, Roberta, Mistretta, Ornella, Epifanio, Maria Stella, Salvato, Angela, D’Agostino, Alberto, Cicero, Giuseppe
Médium: Artigo
Jazyk:Inglês
Vydáno: Elmer Press 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8297050/
https://ncbi.nlm.nih.gov/pubmed/34349854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon1381
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky